NCT01526824View on ClinicalTrials.gov

Lovaza's Effect on Clopidogrel in a Neuro Population

EARLY_PHASE1UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

September 30, 2013

Study Completion Date

September 30, 2013

Conditions
Ischemic StrokeTransient Ischemic Attack
Interventions
DIETARY_SUPPLEMENT

omega-3 polyunsaturated fatty acids (Lovaza)

Lovaza, 1 gram orally daily

Trial Locations (1)

14209

RECRUITING

Millmore Fillmore Gates Hospital, Buffalo

Sponsors

Collaborators (1)

Kaleida Health
All Listed Sponsors
collaborator

Kaleida Health

OTHER

lead

Millard Fillmore Gates Hospital

OTHER

NCT01526824 - Lovaza's Effect on Clopidogrel in a Neuro Population | Biotech Hunter | Biotech Hunter